BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 9, 2017
View Archived Issues
FDA grants orphan drug designation to PLX-200 for late infantile neuronal ceroid lipofuscinosis
Read More
Humanigen, new name for KaloBios
Read More
Selvita partners with the Leukemia & Lymphoma Society to advance SEL-120
Read More
VDAC-1 targeted to inhibit apoptosis in Alzheimer's disease
Read More
Cellectar Biosciences reports positive results from phase I study of CLR-131 in multiple myeloma
Read More
La Jolla Pharmaceutical launches expanded access program for LJPC-501
Read More
MilliporeSigma and Baylor College of Medicine to develop vaccines for neglected diseases
Read More
First animal model of sporadic Alzheimer's disease created and characterized
Read More
Nuclear receptor ROR-gamma antagonism proposed for treating Crohn's disease
Read More
Kite Pharma submits IND for KITE-585
Read More
Galena Biopharma, SELLAS Life Sciences Group enter merger agreement
Read More
Encouraging data presented from first cohort in phase Ib study of TD-1473 in ulcerative colitis
Read More
GlaxoSmithKline patents HIV maturation inhibitors
Read More
Biogen describes novel IRAK-4 inhibitors
Read More
Humanigen completes benznidazole bioavailability study
Read More
Shanghai Hengrui, Jiangsu Hengrui Medicine describe new anti-PCSK9 antibodies
Read More
PreveCeutical Medical and UniQuest sign a nonbinding letter of intent
Read More
Stanford and Washington University present immunoconjugates including chemerin
Read More
Positive topline data from phase II trial of bempedoic acid/ezetimibe combination plus atorvastatin
Read More
University of Southern Denmark discloses bispecific antibodies targeting CD73
Read More
DNA aptamers binding integrin alpha-6 patented by Universitaet Hamburg and UKE
Read More
Brigham and Women's Hospital describes CRISPR/Cas miR-10a/b editing complexes
Read More
House dust mite-derived allergen immunomodulators synthesized at Dankook University
Read More
Fujifilm initiates a phase I study of FF-10101 in relapsed or refractory acute myeloid leukemia
Read More
Stivarga approved in Europe for the second-line systemic treatment of liver cancer
Read More
Mitobridge begins clinical development of MA-0211
Read More
Dermira to license exclusive worldwide rights to lebrikizumab
Read More